Financing ·
Haoxi Health Technology Limited entered into a securities purchase agreement on July 10, 2026, for the sale of 300,000…
HAOHaoxi Health Technology Ltd
Haoxi Health Technology Limited entered into a securities purchase agreement on July 10, 2026, for the sale of 300,000 Class A ordinary shares and 9,700,000 pre-funded warrants at $0.40 per share and $0.07 per warrant respectively, for gross proceeds of $4,000,000. The initial closing of the offering, which occurred on July 13, 2026, resulted in the amount of 5,100,000 Class A ordinary shares issued. The company intends to use the net proceeds for working capital, operating expenses, capital expenditures, and strategic initiatives. Haoxi Health Technology Limited is a health technology company operating in the healthcare sector.